WEDNESDAY, Oct. 22, 2025 For the estimated one-third of people with focal epilepsy who don t respond well to initial medications, new research offers significan
New Study Offers Hope for People With Drug-Resistant Epilepsy
Latest from Blog
STAT+: Failure of Novartis Lp(a) drug raises questions about cardiovascular strategy
CHICAGO — Lipoprotein(a), a genetic risk factor for cardiovascular disease carried by 1 in 5 people, is the target of novel therapies trying to cut down heart attacks, strokes, and deaths in
STAT+: Despite Novo drug’s failure, cardiologists say they will still pursue anti-inflammatories
CHICAGO — Out-of-control inflammation is often called the root of all evil in cardiovascular and metabolic disease. Recent clinical trial results, described in brief in July, showed that while an experimental drug
Group urges passage of bill institutionalizing standard nutrition care
The measures seek to institutionalize NCP as a mandatory component for inpatient and outpatient care in all public Post Views: 2
STAT+: States sue Trump administration again to delay Medicaid work requirements
The Trump administration is facing another lawsuit over its sweeping changes to Medicaid less than a week after a federal judge ruled that implementation of work requirements would cause “irreparable harm.” The
STAT+: MAHA leader Calley Means castigates White House officials as bending to industry
WASHINGTON — The Trump administration’s MAHA agenda has been derailed by corporate interests and the influence of money, a recently departed administration official told the podcaster Joe Rogan in a recording released